Interferon in the treatment of cutaneous T-cell lymphoma.

Published

Journal Article (Review)

All of the recombinant interferons are active agents for the systemic treatment of mycosis fungoides and Sézary syndrome. The response rates are similar to those observed with systemic chemotherapy. There is no clear evidence that combining interferons with other systemic therapies increases the response rates. The combination of interferon with PUVA provides provocative results. The optimal role of interferons in the treatment of mycosis fungoides and Sézary's syndrome is undefined.

Full Text

Duke Authors

Cited Authors

  • Olsen, EA; Bunn, PA

Published Date

  • October 1995

Published In

Volume / Issue

  • 9 / 5

Start / End Page

  • 1089 - 1107

PubMed ID

  • 8522486

Pubmed Central ID

  • 8522486

International Standard Serial Number (ISSN)

  • 0889-8588

Language

  • eng

Conference Location

  • United States